Home  |  Member's Login
 
Indian Cooperative Oncology Network
 
About ICON
Members
Committee
Links
Conference
Photo Gallery
Protocols
Young ICON
We invite you for 37th ICON Conference to be held on 15th to 17th September, 2017 at NCR/Gurgaon. Please Email: akvaid@yahoo.com
Active Protocols

List of Active ICON Protocols

 

 

1.    A Phase II study of Gemcitabine as 4 hour infusion with carboplatin in inoperable stage III and IV NSCLC (Protocol No: ICON/ LUNG/ 0105) Status:

 

2.    Comprehensive Management for patients with Chronic Myeloid Leukemia (Protocol TMC/CML/MO-0401; Version Date 20 April 2004) – a phase II feasibility and tolerability study. Status: Ongoing

 

3.    Combination Chemotherapy for MM (Protocol No: ICON/Hematol-MM/0306) Status: Ongoing

 

4.    A phase II b RCT of Neo adjuvant chemotherapy comparing Paclitaxel, Ifosfamide and Cisplatin with Paclitaxel, Cisplatin and 5-FU in patients with locally advanced head & neck cancer. (Protocol No: ICON/H&N/0601) Status: Completed

 

5.    An open label, multicentre phase I/II dose escalating study of Pablocan (NPB001-05) in patients of chronic myeloid leukemia who have demonstrated resistance / intolerance to the local prevailing standard of care.(Protocol No: ICON/CML/0701) Status: Ongoing

 

6.    An Observational Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients with Platinum Sensitive Epithelial Relapsed Ovarian Cancer. (Protocol No: ICON/Ovary/0703) Status: Ongoing

 

7.    A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (Omacetaxine)  (CGX-635) in the Treatment of Patients with Chronic Myeloid Leukemia (CML) Who have Failed or Are Intolerant to Tyrosine Kinase Inhibitor Therapy (Protocol No. CGX-635-CML-203) Status: Ongoing

 

8.    A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (Omacetaxine) (CGX-635) in the Treatment of Patients with Chronic Myeloid Leukemia (CML) with the T315I BCR-ABL Gene Mutation (Protocol No. CGX-635-CML-202) Status: Completed

 

9.   Neo-Adjuvant Docetaxel + Platinum for Locally Advanced Breast Cancer: A  single arm observational study (ICON/LABC/0108) Status: Discontinued.

Contact Us

Dr Kumar Prabhash
President
ICON Trust
Email: kprabhash1@gmail.com
icon@oncologyindia.org

Tel: 022 24139584

 
 
 
(C) 2008 ICON : All rights reserverd.
Privacy policy
|
Terms of use
Designed by : Nascent
 

cheap air jordan 11 anniversary,cheap jordan shoes sale

cheap air jordan 2012 lite,cheap nike id air max 90

nike free run womens cheap,cheap jordan sneakers for kids